EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

SFXN1 Reduction Alleviates Cerebral Ischemia–Reperfusion Injury by Promoting Neuronal Survival and Reducing Neuroinflammation

Xiangyu Xu, Zhongying Duan, Xin Zhou, Rui Zhao, Jing Xu, Zhaolong Zhang, Mengfei Lv, Qi Wan, Yu Cui iD

CNS Neuroscience & Therapeutics · 2025

DOI: 10.1111/cns.70457 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, 2025. Verfasst von Xiangyu Xu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Neuroregeneration and Neurorehabilitation, Qingdao Medical College, Qingdao University, Qingdao, Shandong, China. Hauptthemen laut MEDLINE: Reperfusion Injury, Neurons, Neuroinflammatory Diseases, Mitochondrial Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Sideroflexin 1 (SFXN1) is an important inner mitochondrial membrane protein that regulates many physiological and pathological events. However, the role of SFXN1 in cerebral ischemia–reperfusion (I/R)‐induced neuronal death remains unclear.

Methods

We employed in vivo injury models of transient middle cerebral artery occlusion (tMCAO) and in vitro models of lipopolysaccharide (LPS) stimulation and oxygen–glucose deprivation/reperfusion (OGD/R) to investigate the regulatory effects of SFXN1 on neuroinflammation and brain injury. Western blotting, immunofluorescence, and real‐time quantitative PCR were utilized to assess SFXN1 expression, proinflammatory signaling pathways activation, and cytokine levels in vitro. Cerebral infarction was evaluated using 2,3,5‐triphenyltetrazolium chloride (TTC) staining and Nissl staining.

Results

SFXN1 expression was upregulated following cerebral I/R injury. Both neurons and microglia exhibited increased SFXN1 expression after oxygen–glucose deprivation/reoxygenation (OGD/R) treatment. SFXN1 knockdown reduced OGD/R‐induced neuronal death and alleviated cerebral I/R injury. Additionally, conditioned medium from SFXN1‐knockdown microglia reduced neurotoxicity in vitro. Mechanistically, SFXN1 induced mitochondrial dysfunction and neuronal death after OGD/R in an iron‐independent manner. Furthermore, SFXN1 promoted the production of proinflammatory cytokines by promoting NF‐κB activation, partially through iron transport in microglia after OGD/R.

Conclusion

This study reveals the novel role of SFXN1 in exacerbating cerebral I/R injury by reducing neuronal survival through the modulation of mitochondrial function and promotion of microglia‐mediated neuroinflammation via NF‐κB activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryNeuronsNeuroinflammatory DiseasesMitochondrial ProteinsBrain IschemiaAnimalsMaleCell SurvivalMiceInfarction, Middle Cerebral ArteryRats, Sprague-DawleyMice, Inbred C57BLRatsMicrogliaGlucose

Stichwörter der Autor:innen

ROSSFXN1ischemic–reperfusion injurymicrogliamitochondrianeuroinflammationneuronsserine

Substanzen

Mitochondrial ProteinsGlucose

Autor:innen und Institutionen

  • Institute of Neuroregeneration and Neurorehabilitation, Qingdao Medical College, Qingdao University, Qingdao, Shandong, China.
  • School of Basic Medicine, Qingdao Medical College, Qingdao University, Qingdao, Shandong, China.
  • Department of Interventional Radiology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong, China.
  • Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, Shandong, China.
  • Faculty of Life and Health, Shenzhen University of Advanced Science, Shenzhen, China.

ORCID-Profile: Yu Cui

Förderung

  • Science and Technology Support Plan for Youth Innovation of Colleges and Universities of Shandong Province of China
  • National Natural Science Foundation of China

Zitieren

APA

Xu, X., Duan, Z., Zhou, X., Zhao, R., Xu, J., Zhang, Z., Lv, M., Wan, Q., & Cui, Y. (2025). SFXN1 Reduction Alleviates Cerebral Ischemia–Reperfusion Injury by Promoting Neuronal Survival and Reducing Neuroinflammation. CNS Neuroscience & Therapeutics. https://doi.org/10.1111/cns.70457

Vancouver

Xu X, Duan Z, Zhou X, Zhao R, Xu J, Zhang Z, et al. SFXN1 Reduction Alleviates Cerebral Ischemia–Reperfusion Injury by Promoting Neuronal Survival and Reducing Neuroinflammation. CNS Neuroscience & Therapeutics. 2025. doi:10.1111/cns.70457

BibTeX
@article{Xu2025,
  author = {Xu, Xiangyu and Duan, Zhongying and Zhou, Xin and Zhao, Rui and Xu, Jing and Zhang, Zhaolong and Lv, Mengfei and Wan, Qi and Cui, Yu},
  title = {SFXN1 Reduction Alleviates Cerebral Ischemia–Reperfusion Injury by Promoting Neuronal Survival and Reducing Neuroinflammation},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2025},
  doi = {10.1111/cns.70457}
}
Kostenlos starten →